COVID-19, Angiotensin Receptor Blockers, and the Brain

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2020 May 10

PMID 32385549

Citations 10

Authors

Juan M Saavedra

Affiliations

Soon will be listed here.

Citing Articles

Effects of COVID-19 on Synaptic and Neuronal Degeneration.

AlQahtani M, Abbas M, Alshahrani M, Alabdullh K, Alqarni A, Alqahtani F Brain Sci. 2023; 13(1).

PMID: 36672112 PMC: 9856402. DOI: 10.3390/brainsci13010131.

Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective.

Kim H, Kang M, Kang G BMC Infect Dis. 2021; 21(1):175.

PMID: 33588797 PMC: 7883762. DOI: 10.1186/s12879-021-05848-8.

A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19.

Hawkins M, Sockalingam S, Bonato S, Rajaratnam T, Ravindran M, Gosse P J Psychosom Res. 2021; 141:110350.

PMID: 33401078 PMC: 7762623. DOI: 10.1016/j.jpsychores.2020.110350.

The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.

de Erausquin G, Snyder H, Carrillo M, Hosseini A, Brugha T, Seshadri S Alzheimers Dement. 2021; 17(6):1056-1065.

PMID: 33399270 PMC: 10431934. DOI: 10.1002/alz.12255.

Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?.

Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim H, Rezaei N Phytomedicine. 2020; 85:153396.

PMID: 33380375 PMC: 7591300. DOI: 10.1016/j.phymed.2020.153396.

References

Hosomi N, Nishiyama A, Matsumoto M . Do RAS inhibitors protect the brain from cerebral ischemic injury?. Curr Hypertens Rev. 2013; 9(2):86-92. DOI: 10.2174/15734021113099990002. View

Batlle D, Wysocki J, Satchell K . Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?. Clin Sci (Lond). 2020; 134(5):543-545. DOI: 10.1042/CS20200163. View

Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

Jeffers S, Tusell S, Gillim-Ross L, Hemmila E, Achenbach J, Babcock G . CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A. 2004; 101(44):15748-53. PMC: 524836. DOI: 10.1073/pnas.0403812101. View

South A, Diz D, Chappell M . COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020; 318(5):H1084-H1090. PMC: 7191628. DOI: 10.1152/ajpheart.00217.2020. View

Marin C, Vilas D, Langdon C, Alobid I, Lopez-Chacon M, Haehner A . Olfactory Dysfunction in Neurodegenerative Diseases. Curr Allergy Asthma Rep. 2018; 18(8):42. DOI: 10.1007/s11882-018-0796-4. View

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q . Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020; 367(6485):1444-1448. PMC: 7164635. DOI: 10.1126/science.abb2762. View

Ren L, Lu X, Danser A . Revisiting the Brain Renin-Angiotensin System-Focus on Novel Therapies. Curr Hypertens Rep. 2019; 21(4):28. PMC: 6449495. DOI: 10.1007/s11906-019-0937-8. View

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

10.

Yamagata R, Nemoto W, Nakagawasai O, Takahashi K, Tan-No K . Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice. Biochem Pharmacol. 2020; 174:113825. DOI: 10.1016/j.bcp.2020.113825. View

11.

Lai C, Wang Y, Wang C, Wang H, Yu C, Chen L . Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874. PMC: 5846309. DOI: 10.2147/COPD.S158634. View

12.

Setiadi A, Korim W, Elsaafien K, Yao S . The role of the blood-brain barrier in hypertension. Exp Physiol. 2017; 103(3):337-342. DOI: 10.1113/EP086434. View

13.

Jia H . Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease. Shock. 2016; 46(3):239-48. DOI: 10.1097/SHK.0000000000000633. View

14.

Elkahloun A, Rodriguez Y, Alaiyed S, Wenzel E, Saavedra J . Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation. Mol Neurobiol. 2018; 56(5):3193-3210. PMC: 6677563. DOI: 10.1007/s12035-018-1300-9. View

15.

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

16.

Adedeji A, Severson W, Jonsson C, Singh K, Weiss S, Sarafianos S . Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol. 2013; 87(14):8017-28. PMC: 3700180. DOI: 10.1128/JVI.00998-13. View

17.

Weiss S, Navas-Martin S . Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005; 69(4):635-64. PMC: 1306801. DOI: 10.1128/MMBR.69.4.635-664.2005. View

18.

Wysocki J, Ye M, Rodriguez E, Gonzalez-Pacheco F, Barrios C, Evora K . Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension. 2009; 55(1):90-8. PMC: 2827767. DOI: 10.1161/HYPERTENSIONAHA.109.138420. View

19.

Diaz J . Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020; 27(3). PMC: 7184445. DOI: 10.1093/jtm/taaa041. View

20.

Readhead B, Haure-Mirande J, Funk C, Richards M, Shannon P, Haroutunian V . Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018; 99(1):64-82.e7. PMC: 6551233. DOI: 10.1016/j.neuron.2018.05.023. View